Welcome to LookChem.com Sign In|Join Free
  • or
[3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester, also known as Methyl 3-formyl-4-(2-iodobenzyloxy)phenylacetate, is a chemical compound characterized by its molecular formula C14H13IO4. It is a methyl ester derivative of 3-formyl-4-(2-iodobenzyloxy)phenylacetic acid, featuring a formyl group, an iodine atom, and a benzyl ether functional group. [3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester is of interest in the fields of organic synthesis and medicinal chemistry, where it may serve as a building block or intermediate for the development of pharmaceuticals with similar structural features.

875050-49-0

Post Buying Request

875050-49-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

875050-49-0 Usage

Uses

Used in Organic Synthesis:
[3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester is used as a building block in organic synthesis for the creation of compounds with similar structural features. Its unique combination of functional groups allows for versatile chemical reactions, facilitating the synthesis of a range of organic compounds.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, [3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester is used as an intermediate in the development of pharmaceuticals. Its structural components may contribute to the design of new drugs with potential therapeutic applications. The exact properties and potential uses of [3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester in medicinal chemistry would require further research and evaluation to ensure safety and efficacy.
Used in Pharmaceutical Development:
[3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester is used as a precursor in the synthesis of pharmaceuticals, potentially leading to the discovery of new drugs with improved therapeutic profiles. Its presence in the molecular structure of these compounds may enhance their pharmacological properties, such as bioavailability, potency, and selectivity.

Check Digit Verification of cas no

The CAS Registry Mumber 875050-49-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,5,0,5 and 0 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 875050-49:
(8*8)+(7*7)+(6*5)+(5*0)+(4*5)+(3*0)+(2*4)+(1*9)=180
180 % 10 = 0
So 875050-49-0 is a valid CAS Registry Number.

875050-49-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name [3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester

1.2 Other means of identification

Product number -
Other names 2-(3-fluoro-4-(trifluoromethyl)phenyl)acetonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:875050-49-0 SDS

875050-49-0Relevant academic research and scientific papers

Stereoselective syntheses of the antihistaminic drug olopatadine and its E-isomer

Bosch, Joan,Bachs, Jordi,Gomez, Antonia M.,Griera, Rosa,Ecija, Marta,Amat, Mercedes

experimental part, p. 6340 - 6344 (2012/10/07)

Practical stereoselective synthetic routes to the antihistaminic drug olopatadine and its E-isomer have been developed, the key steps being a trans stereoselective Wittig olefination using a nonstabilized phosphorus ylide and a stereoselective Heck cyclization. The stereoselectivity of the Wittig reaction depends on both the phosphonium salt anion and the cation present in the base used to generate the ylide.

PROCESS FOR THE PREPARATION OF 11-[(Z)-3-(DIMETHYLAMINO)PROPYLIDENE]-6,11-DIHYDRO-DIBENZ[B,E]OXEPIN-2-YL]-ACETIC ACID

-

Page/Page column 11, (2008/06/13)

Process for the preparation of olopatadine (I), which comprises reacting a compound of formula (V) in the presence of a palladium catalyst to provide a compound of formula (VI), wherein the acid protecting group is removed to provide the compound of formula (I) and if desired, transformation into its salts.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 875050-49-0